Message Me to Request Sample copy
Unavailability of approved drugs thanks to increasing number of product recalls by various developers may be a factor hindering growth of the worldwide Epinephrine Market. As an example, in 2015, Sanofi US voluntarily recalled Auvi-Q (epinephrine injection, USP) on the market including both 0.15 mg and 0.3 mg strengths for hospitals, retailers, and consumers, because of the products had inaccurate dosage delivery, thus included failure to supply intend drug dose.
Figure 1. Global Epinephrine Market price (US$ Mn), by Region, 2017
Message Me to Request PDF Brochure
Figure 2. Global Epinephrine Market Share (%), by Product Type, 2018 and 2026
Major players operating within the global Epinephrine Market include Mylan N.V., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Impax Laboratories, Inc., Kaleo, Inc., Adamis Pharmaceuticals Corporation, Bausch Health Companies, and ALK- Abello A/S.
Market players are focused on launching cost effective versions for patients affected by severe allergies, requiring constant access to life-saving epinephrine, thereby providing affordable options and propelling the market growth.
For instance, in August 2018, Teva Pharmaceuticals received the Food and Drug Administration (FDA) approval for first generic versions of EpiPen and EpiPen Jr, for the emergency treatment of allergies, including life-threatening allergies (anaphylaxis), in adults, and pediatric patients weighing quite 33 pounds.
Edit your job
Opening message is automatically displayed as your first message in the order detail page.
There are no extra services
Welcome to Freelance Global Gigs.
Post your Gigs at Freelance Global Gigs - We have opportunities for everyone.